Toggle Accessibility Tools

News

September 29, 2015 Thornberg & Watts receive COM Faculty award

Five Michigan State University College of Osteopathic Medicine faculty members received the College Advisory Council Awards at the faculty meeting on Sept. 29. Margaret Kingry, associate professor of pediatrics, presented the recognition on behalf of the council.

Nikita Joshi wins 'best presentation' award at Toledo Colloquium June 13, 2015 Nikita Joshi wins 'best presentation' award at Toledo Colloquium

Congratulations Nikita on winning a best presentation award at the colloquium in Toledo.

Dr. Patricia Ganey VP-Elect of SoT February 1, 2015 Dr. Patricia Ganey VP-Elect of SoT

Congratulations to Dr. Patti Ganey who has been elected Vice-President of the Society of Toxicology (SoT) and will become president after that.

August 22, 2014 2014 Summer Graduates

Congratulations to the SUMMER 2014 graduates of our MS in Pharmacology & Toxicology program

Watts Lab Receives NIH Grant August 1, 2014 Watts Lab Receives NIH Grant

The National Institute of Health / National Heart, Lung and Blood Institute has awarded a grant to Michigan State University ( P.I. Dr. Stephanie Watts, Department of Pharmacology & Toxicology ) for the project “Chemerin as a Link Between Obesity and Blood Pressure

July 27, 2014 Michigan scientists give hope to patients with rare scleroderma

"Most of the time, Sheri Hicks doesn’t wear makeup or style her hair. It isn’t because she doesn’t care about how she looks or doesn’t want to be bothered. It’s because she physically can’t do it. Hicks, 42, of Farmington has an autoimmune disorder called scleroderma, which causes fibrosis, or the thickening and hardening of the skin, along with pain, sensitivity to heat and cold and other effects."

UM / MSU Team Awarded NIH Funding to Develop Potential Therapeutics for Scleroderma July 9, 2014 UM / MSU Team Awarded NIH Funding to Develop Potential Therapeutics for Scleroderma

U-M and MSU researchers have joined together to develop novel compounds for the treatment of scleroderma, supported by a three-year, $2M award from the National Institutes of Health (NIH). "Dr. [Scott] Larsen is a member of a team of basic science and clinician researchers at U-M and MSU who have joined forces to further the development of novel compounds for the treatment of scleroderma. The initial discovery was made by Dr. Richard Neubig, chair of the pharmacology and toxicology department at Michigan State University, via high-throughput screening at the Center for Chemical Genomics at the U-M Life Sciences Institute."

May 2, 2014 2014 Spring Graduates

Congratulations to the Spring 2014 graduates of our MS in Pharmacology & Toxicology program.

April 23, 2014 Groundbreaking scleroderma research being done at Michigan State University

"[EAST] LANSING, Mich. - Groundbreaking research is being done at Michigan State University for a debilitating disease that hardens skin. "

March 27, 2014 MSU-National Society of Toxicology Meeting in Phoenix, AZ.

Each year the Society of Toxicology presents awards to distinguished toxicologists and students from around the world. At their 2014 annual meeting, a diverse group of faculty and students from Michigan State University were selected

April 14, 2014 Flipping the Switch on Scleroderma

From MSU Today 4/3/2014 - "Scleroderma is a rare and often fatal disease, causing the thickening of tissue, that currently lacks a cure and any effective treatments. A group of researchers, including a Michigan State University professor, is looking to change that."